RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 40 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,139 | +28.7% | 8,554 | +10.9% | 0.00% | – |
| Q2 2023 | $50,604 | -57.1% | 7,714 | -61.0% | 0.00% | – |
| Q1 2023 | $118,000 | +262122.2% | 19,776 | +1.6% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 19,466 | -26.1% | 0.00% | – |
| Q3 2022 | $88,000 | +633.3% | 26,357 | +546.5% | 0.00% | – |
| Q1 2022 | $12,000 | -42.9% | 4,077 | +67.0% | 0.00% | – |
| Q4 2021 | $21,000 | -8.7% | 2,442 | -21.8% | 0.00% | – |
| Q3 2021 | $23,000 | -68.5% | 3,121 | -60.0% | 0.00% | – |
| Q2 2021 | $73,000 | – | 7,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |